DI CARLO, EMMA
 Distribuzione geografica
Continente #
NA - Nord America 4.215
EU - Europa 3.775
AS - Asia 2.449
SA - Sud America 258
AF - Africa 13
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 10.717
Nazione #
US - Stati Uniti d'America 4.178
CN - Cina 840
SG - Singapore 793
UA - Ucraina 773
IE - Irlanda 629
TR - Turchia 558
GB - Regno Unito 498
IT - Italia 467
SE - Svezia 448
FR - Francia 368
DE - Germania 252
BR - Brasile 222
FI - Finlandia 152
IN - India 140
RU - Federazione Russa 120
VN - Vietnam 33
CA - Canada 21
HK - Hong Kong 17
AR - Argentina 15
BE - Belgio 14
MX - Messico 14
IQ - Iraq 11
AT - Austria 10
NL - Olanda 10
PK - Pakistan 9
PL - Polonia 9
BD - Bangladesh 8
IL - Israele 8
CL - Cile 7
EG - Egitto 6
ES - Italia 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
JP - Giappone 5
EU - Europa 4
RO - Romania 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
CO - Colombia 3
GR - Grecia 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
PY - Paraguay 3
VE - Venezuela 3
AU - Australia 2
BH - Bahrain 2
CH - Svizzera 2
KE - Kenya 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
GE - Georgia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
LB - Libano 1
MA - Marocco 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.717
Città #
Jacksonville 841
Chandler 702
Dublin 626
Singapore 465
Southend 387
Dearborn 382
Princeton 310
Izmir 264
Nanjing 251
Wilmington 173
Beijing 140
Cambridge 140
The Dalles 131
Altamura 98
Nanchang 78
Ann Arbor 73
New York 72
Santa Clara 72
Boardman 69
Chieti 60
Woodbridge 54
Shenyang 47
Pescara 46
Ashburn 43
Hebei 39
Romola 37
Kunming 36
Grevenbroich 34
Dong Ket 32
Los Angeles 32
Jiaxing 30
Tianjin 26
Hefei 21
Hangzhou 20
Houston 20
Jinan 19
São Paulo 19
Norwalk 18
Düsseldorf 17
Hong Kong 17
Orange 16
Changsha 15
Guangzhou 15
Chennai 14
Helsinki 13
Lanciano 12
Brussels 11
Falls Church 11
Auburn Hills 10
Augusta 10
Camerino 10
San Francisco 10
Leawood 9
Mexico City 9
Nuremberg 9
Toronto 9
Washington 9
Changchun 8
Lanzhou 8
Ningbo 8
San Mateo 8
Baghdad 7
Milan 7
Munich 7
Phoenix 7
Rio de Janeiro 7
Warsaw 7
Zhengzhou 7
Brooklyn 6
Chicago 6
Shanghai 6
Tappahannock 6
Bari 5
Boston 5
Caxias do Sul 5
London 5
Manchester 5
Moscow 5
Porto San Giorgio 5
Tandil 5
Torino 5
Andover 4
Baotou 4
Brno 4
Chengdu 4
Curitiba 4
Lappeenranta 4
Montreal 4
Nichelino 4
Padova 4
Rome 4
Taizhou 4
Tashkent 4
Terni 4
Xian 4
Atlanta 3
Belo Horizonte 3
Cairo 3
Campinas 3
Dallas 3
Totale 6.354
Nome #
Interleukin-30/IL-27p28 shapes prostate cancer stem-like cell behavior and is critical for tumor onset and metastasization 115
The prostate-associated lymphoid tissue (PALT) is linked to the expression of homing chemokines CXCL13 and CCL21. 111
Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice. 105
Interleukin 6 gene transfected mouse mammary adenocarcinoma cells displaying an "in vitro" increased cell growth show an "in vivo" low tumor progression and a high metastatic potential. 100
EDAP a member of TNF ligand superfamily is able to induce macrophage-granulocyte cross-talk. 100
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype and predicts clinical outcome 99
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. 98
A "stealth effect": adenocarcinoma cells engineered to express TRAIL elude tumor-specific and allogeneic T cell reactions. 97
IL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions. 97
SNAI2/Slug gene is silenced in prostate cancer and regulates neuroendocrine differentiation, metastasis-suppressor and pluripotency gene expression 96
Endomyocardial infiltration by B and NK cells foreshadows the recurrence of cardiac allograft rejection 95
Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. 95
CD25+ Regulatory T Cell Depletion Augments Immunotherapy of Micrometastases by an IL-21-Secreting Cellular Vaccine. 92
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. 92
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 92
Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver 91
Targeting tumor-related immunosuppression for cancer immunotherapy. 91
In vivo studies of cytokines and growth factors involved in inflammation by using engineered tumor cells as biological minipumps. 90
Tumor cells engineered with IL-12 and IL-15 genes induce protective antibody responses in nude mice. 89
Interaction Between Endothelial Cells and the Secreted Cytokine Drives the Fate of An IL4- or An IL 5-Transduced Tumour 88
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 88
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 88
SPARC/Osteonectin production by tumor infiltrating macrophages promotes breast cancer metastatization. 88
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 88
Androgen Deprivation Boosts Prostatic Infiltration of Cytotoxic and Regulatory T Lymphocytes and Has No Effect on Disease-Free Survival in Prostate Cancer Patients. 88
Quilty effect has the features of lymphoid neogenesis and shares CXCL13-CXCR5 pathway with recurrent acute cardiac rejections 88
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. 87
CD56(bright)perforin(low) noncytotoxic human NK cells are abundant in both healthy and neoplastic solid tissues and recirculate to secondary lymphoid organs via afferent lymph 87
OX40 ligand-transduced tumor cell vaccine synergizes with GM-CSF and requires CD40-Apc signaling to boost the host T cell antitumor response. 86
Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. 86
Interleukin-30 Promotes Breast Cancer Growth and Progression 86
Immune Events Associated with the Cure Established Tumors and Spontaneous Metastases by Local and Systemic Interlukin 12 85
Targeting of IL-12 to human non small cell lung cancer counters tumor growth in vivo 85
Absence of IL-12Rβ2 in CD33(+)CD38(+) pediatric acute myeloid leukemia cells favours progression in NOD/SCID/IL2RγC-deficient mice. 85
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 85
Interleukin-27 re-educates intratumoral myeloid cells and down-regulates stemness genes in non-small cell lung cancer 85
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 85
Local release of IL-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti- inflammatory activity resulting in a delayed tumour rejection. 84
Interleukin 12-mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice 84
Constitutive expression of IL-12RB2 on human multiple myeloma cells delineates a novel therapeutic target. 84
Interleukin-23 acts as antitumor agent on childhood B-acute lymphoblastic leukemia cells. 84
The Immune Response Elicited by Mammary Adenocarcinoma Cells Transduced with Interferon-y and Cytosine Deaminase Genes Cures Lung Metastases by Parental Cells 83
The role of B lymphocytes and NK cells in cardiac allograft rejection. 83
Interferon (IFN)-beta Gene Transfer into TS/A Adenocarcinoma Cells and Comparison with IFN-alpha. Differential Effects on Tumorigenicity and Host Response 82
Dendritic cell recognition by ILC3 via DNAM-1 triggers pro-inflammatory reciprocal cell activations 82
Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. 81
Immunopathological alterations of the prostate-associated lymphoid tissue (PALT) by androgen ablation in patients with prostate cancer 81
Immunological mechanisms elicited at the tumour site by lymphocyte activation gene-3 (LAG-3) versus IL-12: sharing a common Th1 anti-tumour immune pathway 81
The prostate-associated lymphoid tissue (PALT) is driven by CXCL13 and CCL21 expression. 81
Interleukin-30 expression in prostate cancer and its draining lymph nodes correlates with advanced grade and stage 81
Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model 81
Induced somatic inactivation of STAT3 in mice triggers the development of a fulminant form of enterocolitis. 80
Neutrophils in anti-cancer immunological strategies: old players in new games 80
The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance. 80
Upregulation of TMEM16A protein in bronchial epithelial cells by bacterial pyocyanin 80
Down regulation of major histocompatibility complex class I expression in mammary carcinoma of Her-2/neu trangenic mice 79
Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes. 79
Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185neu DNA vaccination in Her-2/neu transgenic BALB/c mice. 78
The Quilty Effect: an actor in search of a part 78
Proinflammatory cytokines IL1 and IL6 are autocrine and/or paracrine growth factors for normal and neoplastic epithelial cells from human uterine cervix. 78
Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy. 78
Interleukin 6 gene-transfected mouse mammary adenocarcinoma: tumour cell growth and metastatic potential. 77
A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia. 77
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 77
The prostate-associated lymphoid tissue (PALT) is heavily compromised in prostate cancer but differently altered depending on androgen ablation. 77
The antitumor potential of Interleukin-27 in prostate cancer 77
Mammary carcinoma provides highly tumourigenic and invasive reactive stromal cells. 77
Signaling through 3',5'-Cyclic Adenosine Monophosphate and Phosphoinositide-3 Kinase Induces Sodium/Iodide Symporter Expression in Breast Cancer. 76
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 76
IL-12 mediated prevention of spontaneous tumors in C-neu transgenic inbred BALB/c and FVB mice. 76
Interleukin-27 Acts as Multifunctional Anti-Tumor Agent in Multiple Myeloma. 76
Immunological prevention of a multigene cancer syndrome. 75
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 75
The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. 75
SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis 75
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease. 75
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 74
Neutrophils in the antitumoral immune response 74
p185neu protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma 73
Methylation of the IL-12Rbeta2 gene as novel tumor escape mechanism for pediatric B-acute lymphoblastic leukemia cells. 73
The combined action of IL-15 and IL-12 gene transfer can induce tumor cell rejection without T and NK cell involvement. 73
Direct inhibition of human acute myeloid leukemia cell growth by IL-12. 73
Network of immunoregolatory cell subsets and mediators involved in human cardiac allograft rejection. 73
Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice 72
Prevention by delay: nonspecific immunity elicited by IL-12 hinders Her-2/neu mammary carcinogenesis in transgenic mice. 72
Therapy of lung metastases through combined vaccination with carcinoma cells engineered to release IL-13 and IFN-gamma. 71
The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al. 71
L'angiogenesi e le alterazioni vascolari giocano un ruolo cruciale nel promuovere o inibire la crescita tumorale di un adenocarcinoma mammario murino ingegnerizzato con i geni di IL5 o di IL4. 70
Nonredundant roles of antibody, cytokines, and perforin in the eradication of established Her-2/neu carcinomas. 69
Insertion of the DNA for the 163-171 peptide of IL1beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. 69
Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination. 69
Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers 69
IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis 69
Intralesional injection of adenovirus encoding CC chemokine ligand 16 inhibits mammary tumor growth and prevents metastatic-induced death after surgical removal of the treated primary tumor. 69
DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice 68
Immunization in tumor prevention. 68
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumor escape from immuno-surveillance. 68
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival 67
The intriguing role of polymorphonuclear neutrophils in antitumor reactions. 67
Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. 67
Totale 8.174
Categoria #
all - tutte 47.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.285


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202026 0 0 0 0 0 0 0 0 0 0 0 26
2020/2021892 148 4 149 9 97 224 14 6 38 126 19 58
2021/2022585 29 9 8 91 52 16 11 52 40 25 71 181
2022/20232.099 175 212 114 254 222 442 114 142 290 51 54 29
2023/2024791 77 34 48 20 36 246 231 15 1 12 8 63
2024/20252.041 157 318 316 98 45 64 46 155 299 134 305 104
Totale 11.266